Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis.

IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY
Dilara Turan Gokce, Derya Ari, Hale Gokcan, Osman Aydin, Nesrin Turhan, Meral Akdogan Kayhan
{"title":"Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis.","authors":"Dilara Turan Gokce,&nbsp;Derya Ari,&nbsp;Hale Gokcan,&nbsp;Osman Aydin,&nbsp;Nesrin Turhan,&nbsp;Meral Akdogan Kayhan","doi":"10.14744/hf.2022.2022.0018","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatoportal sclerosis (HPS) is an idiopathic non-cirrhotic portal hypertension (INCPH) characterized by hypersplenism, portal hypertension, and splenomegaly. Hepatocellular carcinoma (HCC) is the most common form of liver cancer. Non-cirrhotic portal hypertension is an extremely rare cause of HCC. A 36-year-old woman was referred to our hospital with esophageal varices. All serologic tests for etiology were negative. Serum ceruloplasmin and serum Ig A-M-G were normal. In the follow-up, two liver lesions were identified on a triple-phase computer. The lesions had arterial enhancement but no washout in the venous phase. In the magnetic resonance imaging examination, differentiation in favor of HCC was considered at one of the lessions. Radiofrequency ablation therapy was first applied to a patient who had no signs of metastasis. Within 2 months, the patient underwent a living donor liver transplant. In explant pathology, well-differentiated HCC and HPS were considered the cause of non-cirrhotic portal hypertension. The patient has been followed without relapse for 3 years. The development of HCC in INCPH patients is still debatable. Despite the presence of liver cell atypia and pleomorphism in nodular regenerative hyperplasia liver specimens, a causal link between HCC and INCPH is yet to be established.</p>","PeriodicalId":29722,"journal":{"name":"Hepatology Forum","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/80/hf-4-035.PMC9951896.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology Forum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/hf.2022.2022.0018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Hepatoportal sclerosis (HPS) is an idiopathic non-cirrhotic portal hypertension (INCPH) characterized by hypersplenism, portal hypertension, and splenomegaly. Hepatocellular carcinoma (HCC) is the most common form of liver cancer. Non-cirrhotic portal hypertension is an extremely rare cause of HCC. A 36-year-old woman was referred to our hospital with esophageal varices. All serologic tests for etiology were negative. Serum ceruloplasmin and serum Ig A-M-G were normal. In the follow-up, two liver lesions were identified on a triple-phase computer. The lesions had arterial enhancement but no washout in the venous phase. In the magnetic resonance imaging examination, differentiation in favor of HCC was considered at one of the lessions. Radiofrequency ablation therapy was first applied to a patient who had no signs of metastasis. Within 2 months, the patient underwent a living donor liver transplant. In explant pathology, well-differentiated HCC and HPS were considered the cause of non-cirrhotic portal hypertension. The patient has been followed without relapse for 3 years. The development of HCC in INCPH patients is still debatable. Despite the presence of liver cell atypia and pleomorphism in nodular regenerative hyperplasia liver specimens, a causal link between HCC and INCPH is yet to be established.

Abstract Image

罕见的肝细胞癌表现:肝门静脉硬化。
肝门脉硬化(HPS)是一种特发性非肝硬化门脉高压(INCPH),以脾功能亢进、门脉高压和脾肿大为特征。肝细胞癌(HCC)是最常见的肝癌。非肝硬化门静脉高压症是HCC极为罕见的病因。一名36岁女性因食道静脉曲张转诊至我院。所有病原学血清学检查均为阴性。血清铜蓝蛋白、Ig A-M-G正常。在随访中,在三相计算机上发现了两个肝脏病变。病变有动脉强化,但在静脉期没有消失。在磁共振成像检查中,在一个教训中考虑了有利于HCC的分化。射频消融治疗首次应用于无转移迹象的患者。2个月内,患者接受了活体肝移植。在外植体病理中,分化良好的HCC和HPS被认为是导致非肝硬化门静脉高压症的原因。随访3年无复发。HCC在INCPH患者中的发展仍有争议。尽管在结节性再生增生肝标本中存在肝细胞异型性和多形性,但HCC与INCPH之间的因果关系尚不明确。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
12.50%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信